Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
about
Escaping Antiangiogenic Therapy: Strategies Employed by Cancer CellsControl of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in GlioblastomaThe twisted survivin connection to angiogenesisIsolation and Culture Expansion of Tumor-specific Endothelial CellsTargeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenograftsImmunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.Molecular Acoustic Angiography: A New Technique for High-resolution Superharmonic Ultrasound Molecular ImagingAssessment of Molecular Acoustic Angiography for Combined Microvascular and Molecular Imaging in Preclinical Tumor Models.Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.Adaptive windowing in contrast-enhanced intravascular ultrasound imaging.Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells.High Resolution Ultrasound Superharmonic Perfusion Imaging: In Vivo Feasibility and Quantification of Dynamic Contrast-Enhanced Acoustic Angiography.Contribution of Adipose Tissue to Development of Cancer.Dual-Frequency Piezoelectric Endoscopic Transducer for Imaging Vascular Invasion in Pancreatic Cancer.The role of tumor microenvironment in resistance to anti-angiogenic therapy.Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia.Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.
P2860
Q28067753-BA16BA7E-2FA8-469F-AE77-7CA1E3B84843Q29994573-2035BCED-A6FF-42F8-BA25-D897B7C20E66Q33868524-4B38B22D-CF3B-4AEB-856E-E82064E301C4Q36301932-10C569E4-4762-4C82-9144-40A752C2DAF0Q36408245-717468EF-3C78-4027-B853-51808139A7D3Q36545764-435B3163-BD10-4471-9758-2BAE81A8EF0FQ38619615-ED4E7682-BC47-4802-BF22-723AC2D06703Q38810997-051B0417-1D52-44B7-A77A-6070576ED0D1Q38831825-8AF58EB0-11D5-4653-B1BD-5DDDC540AA88Q39188509-0DB33F3E-64B5-4383-BEAB-544FDB625E53Q39657690-E1AEEB9B-5B80-4087-B762-E2F17BE363B3Q39781650-A23D6F0B-8D8A-4113-BF0F-37272E2A6211Q41679466-A81409AC-BC90-43CD-AF9E-45AD3C75495EQ44868107-01032AED-33E8-450E-92FD-339716FF87CEQ49164235-3EC0BD1F-233C-47CF-9DFB-BE06748AA735Q50881296-65E81F7A-9204-4C6E-9B8B-6323DBEDB1B6Q52645823-23E81437-373F-47BF-8C43-21431ADB2299Q53168767-C1B0E84D-1584-44C7-8AB9-ABC7700EFB7AQ53671693-47D989C0-CABB-4F15-9493-963DC99F685EQ54114273-71644CB6-1CE8-42B2-8D40-DEF82F368815Q55190969-56ABD37D-4232-4570-864D-66DD545AF808Q55503300-C62E67FA-5D67-40CD-B161-D1092A49D503
P2860
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@ast
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@en
type
label
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@ast
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@en
prefLabel
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@ast
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@en
P2093
P2860
P356
P1476
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.
@en
P2093
Andrew C Dudley
David M Irvin
David W Ollila
James M Dunleavey
Janiel M Shields
Joshua Thompson
Juan M Melero-Martin
Paul A Dayton
P2860
P2888
P356
10.1038/NCOMMS6200
P407
P577
2014-10-22T00:00:00Z
P5875
P6179
1006860817